Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis [0.03%]
胃癌中肿瘤浸润淋巴细胞的预后作用：系统性回顾和meta分析
Xiaoqing Cao,Yurou Kang,Ping Tai et al.
Xiaoqing Cao et al.
Background: To analyze the relationship between tumor-infiltrating lymphocytes (TILs) subtypes and infiltration locations and the prognosis of gastric cancer (GC) patients. ...
Current advances in nanoparticle-based approaches for the hepatocellular carcinoma treatment [0.03%]
基于纳米颗粒的肝细胞癌治疗的最新进展
Sathishbabu Paranthaman,Umme Hani,Riyaz Ali M Osmani et al.
Sathishbabu Paranthaman et al.
Hepatocellular carcinoma (HCC) is the most common form of liver (LC) with a high mortality rate, driven by risk factors including viral hepatitis, alcoholic liver disease, and nonalcoholic steatohepatitis. The incident of HCC increases 2-4%...
Expansion of interventional endoscopy and day-case procedures: A nationwide longitudinal study of gastrointestinal endoscopy in France [0.03%]
法国全国范围内胃肠内镜的纵向研究：介入性内镜和日间手术的发展状况
Hervé-Pierre Toudic,Marie Morvan,Noémi Reboux et al.
Hervé-Pierre Toudic et al.
Background: An accurate assessment of the evolution of GI endoscopy volumes is warranted to identify long-term trends and to help anticipate training, infrastructure and human resource needs. The main objective of this lo...
Dan-Lei Han,Jian Zha,Lin-Yan Wan et al.
Dan-Lei Han et al.
Safety and efficacy of the enhanced recovery after surgery protocol in hepatectomy for liver cancer [0.03%]
肝癌患者肝脏切除术后加速康复方案的疗效及安全性分析
Quan Lv,Ying-Chun Xiang,Yan-Yu Qiu et al.
Quan Lv et al.
Purpose: The aim of this research was to evaluate the efficacy and safety of enhanced recovery after surgery (ERAS) protocol in hepatectomy patients with liver cancer. ...
Intra- and inter-patient diversity in hepatocellular carcinoma based on phosphorylation profiles-A pilot study in a single institution [0.03%]
基于磷酸化谱的肝细胞癌的院内和院间异质性——单中心初步研究
Kan Toriguchi,Etsuro Hatano,Makoto Sudo et al.
Kan Toriguchi et al.
Background: Recent studies have addressed the efficacy of targeted drugs against hepatocellular carcinoma. However, most tumors escape a single kinase inhibition; co-inhibition of additional signaling pathways re-sensitiz...
Christophe Souaid,Eddy Fares,Paul Primard et al.
Christophe Souaid et al.
Crohn's disease (CD) is a chronic inflammatory condition of the gastrointestinal tract where early diagnosis and timely, appropriate management are essential to prevent severe complications and reduce the need for surgery. This review sough...
Superiority of frailty over age in predicting outcomes among clostridium difficile patients: Evidence from national data [0.03%]
虚弱比年龄更能够预测艰难梭菌感染患者的预后：基于全国数据的证据
Ali Jaan,Umer Farooq,Abdulrahman Alyounes Alayoub et al.
Ali Jaan et al.
Background: Clostridium difficile infection (CDI) has become a significant healthcare issue with increasing morbidity and mortality in the US and Europe. Frailty, characterized by reduced physical reserves and resistance ...
Prolonged survival in women with hepatocellular carcinoma: A French observational study [0.03%]
法国观察性研究中的女性肝细胞癌长期生存期分析
Cécilia Busso,Jean-Charles Nault,Richard Layese et al.
Cécilia Busso et al.
Background and aim: Less than 25 % of hepatocellular carcinoma (HCC) occurs in women, in whom prognosis could be better. Due to the lack of date in Europe, this study aims to assess survival of patients with HCC according...
Non selective beta-blockers prevent PHT-related complications occurrence in HCC patients with esophageal varices treated by TACE [0.03%]
非选择性β阻滞剂可预防经导管动脉化疗栓塞治疗食管静脉曲张的肝细胞癌患者的并发症发生率
Manon Allaire,Hélène Garcia,Louis Meyblum et al.
Manon Allaire et al.
Introduction: We aimed to investigate the parameters associated with portal hypertension (PHT)-related complications occurrence in hepatocellular carcinoma (HCC) patients treated by transarterial chemoembolization (TACE),...